This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB03866/identifier/chemspider/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03866/identifier/chebi/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03866/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03866/identifier/pubchem-compound/
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03866/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03866/identifier/drugbank/

Statements

Subject Item
n2:DB03866
rdf:type
n4:Drug
n4:description
A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem]
n4:group
experimental
owl:sameAs
n7:DB03866 n8:DB03866
dcterms:title
Prostaglandin G2
adms:identifier
n10:5280883 n11:46509030 n12:DB03866 n13:PGX n14:27647 n15:4444406
n4:IUPAC-Name
n5:271B4A37-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B4A3D-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B4A3C-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B4A39-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B4A3A-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B4A3B-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B4A35-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B4A33-363D-11E5-9242-09173F13E4C5 n5:271B4A36-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B4A34-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B4A43-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B4A44-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B4A3E-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B4A3F-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4A41-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4A40-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4A42-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B4A49-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B4A4B-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B4A4C-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B4A48-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B4A47-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B4A4A-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B4A38-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B4A45-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B4A46-363D-11E5-9242-09173F13E4C5